Titre :
  • Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.
Auteur : Pajk, Bojana ; Cufer, T ; Canney, P A ; Ellis, P. ; Cameron, David A ; Blot, Emmanuel ; Vermorken, Jan Baptist ; Coleman, R ; Marreaud, Sandrine ; Bogaerts, J ; Basaran, Gul ; Piccart-Gebhart, Martine
Informations sur la publication : Breast, 17, 2, (page 180-185)
Statut de publication : Publié, 2008-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Breast cancer
Capecitabine
Efficacy
Monotherapy
Toxicity
Vinorelbine
Mots-clés MeSH : Adult
Aged
Anthracyclines -- therapeutic use
Antimetabolites, Antineoplastic -- administration & dosage
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Bridged Compounds -- therapeutic use
Deoxycytidine -- administration & dosage
Deoxycytidine -- analogs & derivatives
Drug Therapy, Combination
Female
Fluorouracil -- administration & dosage
Fluorouracil -- analogs & derivatives
Humans
Middle Aged
Taxoids -- therapeutic use
Treatment Outcome
Vinblastine -- administration & dosage
Vinblastine -- analogs & derivatives
Note : Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0960-9776 
info:doi/10.1016/j.breast.2007.09.002
info:pii/S0960-9776(07)00193-2
info:pmid/17976988